Scilex Holding (NASDAQ:SCLXW – Get Free Report) shares shot up 22.5% on Friday . The stock traded as high as $0.25 and last traded at $0.25. 6,513 shares changed hands during trading, an increase of 154% from the average session volume of 2,569 shares. The stock had previously closed at $0.20.
Scilex Trading Up 22.5 %
The firm’s 50-day moving average is $0.28 and its two-hundred day moving average is $0.31.
About Scilex
Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura in adults; and GLOPERBA, a liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.
See Also
- Five stocks we like better than Scilex
- What is the Nasdaq? Complete Overview with History
- ServiceTitan Made Waves in Its IPO, But Is the Stock a Buy?
- Bank Stocks – Best Bank Stocks to Invest In
- Netflix: Is This the Perfect Time to Buy a Streaming Powerhouse?
- How to Invest in Biotech Stocks
- Goldman Sachs Unveils 3 Massive Opportunities for 2025 Investors
Receive News & Ratings for Scilex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scilex and related companies with MarketBeat.com's FREE daily email newsletter.
